Emmaus Support Program Gives US Patients Low-cost Access to Endari
Emmaus Life Sciences has launched a program that will allow eligible sickle cell disease patients in the U.S. to access its Endari (L-glutamine) medication at low cost or free of charge. Patients who currently lack insurance coverage or financial means to afford treatment may reach out to Endari’s…